Skip to main content
Vetoquinol SA logo

Vetoquinol SA — Investor Relations & Filings

Ticker · VETO ISIN · FR0004186856 LEI · 969500YP0AETQIK48R39 PA Manufacturing
Open in API
Filings indexed 299 across all filing types
Latest filing 2023-06-12 Regulatory Filings
Country FR France
Listing PA VETO

About Vetoquinol SA

https://www.vetoquinol.com/en

Vetoquinol SA is a global animal health company that researches, develops, produces, and markets veterinary medicines and non-medicinal products. The company provides solutions for both companion animals (cats and dogs) and livestock (cattle and pigs). Its product portfolio addresses a wide range of therapeutic areas, including mobility, dermatology, anti-parasitics, antibiotics, internal medicine, and behavior management. Founded in 1933, the independent, family-owned business focuses on innovation and maintaining a close relationship with veterinary professionals to support animal well-being.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 90% confidence The document is titled 'PRESS RELEASE' and dated June 12, 2023. It discusses the company's 90th anniversary, its focus on R&D, innovation strategy, and provides contact information for Group Communications and Investor Relations. This format strongly suggests an official announcement intended for the public and media regarding company news, rather than a formal regulatory filing like a 10-K, an earnings release (ER) which focuses on financial figures, or a detailed investor presentation (IP). Since it is a general press release announcing company milestones and strategy updates, and it doesn't fit the specific definitions for dividend (DIV), management change (MANG), or capital change (CAP), the most appropriate general category for a non-financial, non-regulatory announcement of this nature is the fallback category, Regulatory Filings (RNS), as it serves as a general corporate announcement.
2023-06-12 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 99% confidence The document explicitly details events that occurred during the 'Assemblée générale mixte des actionnaires de Vetoquinol' (Annual General Meeting of Shareholders). Key elements confirming this are: the date (25 mai 2023), the mention of resolutions being adopted (approval of 2022 accounts, dividend setting), and significant governance changes announced (resignation of the Chairman and appointment of a new one). This content directly relates to the proceedings and outcomes of an AGM. Therefore, the appropriate classification is AGM Information (AGM-R).
2023-05-25 French
Inside Information / Other news releases
AGM Information Classification · 99% confidence The document explicitly mentions the 'Combined General Meeting of Vetoquinol shareholders was held on Thursday 25 May 2023'. It details resolutions adopted, including the approval of 2022 financial statements, setting the dividend, and announcing board appointments/resignations. The key event described is the AGM itself and the immediate outcomes/announcements made there, specifically concerning board changes and voting results. Since it covers the results of the shareholder vote (adoption of resolutions, dividend approval) and significant management changes announced during the meeting, it strongly aligns with AGM-R (AGM Information) and potentially DVA (Declaration of Voting Results & Voting Rights Announcements). However, the primary context is the meeting itself and the associated governance/management announcements. Given the focus on the meeting proceedings and the adoption of resolutions, AGM-R is the most fitting primary category. The document is short and appears to be a press release summarizing the meeting, not the detailed voting results document itself (which would be DVA) or the full annual report (10-K).
2023-05-25 English
Inside Information / Other news releases
Regulatory Filings Classification · 97% confidence The document is titled 'PRESS RELEASE' and dated May 2, 2023. It discusses the company's 90th anniversary, its strategic focus on 'Essential' products, and its commitment to a 'One Health' approach. It concludes with contact information for Group Communications and Investor Relations, and a brief 'ABOUT VETOQUINOL' section. This format is characteristic of a general corporate announcement or press release intended for the public and media, rather than a formal regulatory filing like a 10-K, IR, or ER. Since it is a general announcement and does not fit the specific categories like AGM-R, ER, or CT, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory/corporate announcements that aren't covered by more specific codes.
2023-05-02 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 96% confidence The document is titled 'COMMUNIQUÉ DE PRESSE' (Press Release) and dated May 2, 2023. It discusses Vetoquinol's 90th anniversary and its strategic focus on 'Essential' products. It provides company background, product portfolio details, and contact information for press and investor relations. This format strongly suggests a general corporate announcement or news release rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). Since it is a press release announcing general corporate strategy and milestones, and it doesn't fit the specific categories like AGM-R, 10-K, ER, or CT, the most appropriate general category is Regulatory Filings (RNS), which often serves as a catch-all for official, non-standard announcements, although it is primarily a press release. Given the options, RNS is the best fit for a general corporate communication that isn't a specific financial report or management change.
2023-05-02 French
Informations privilégiées / Autres communiqués
Earnings Release Classification · 99% confidence The document is titled 'COMMUNIQUÉ DE PRESSE' (Press Release) and discusses the company's 90th anniversary, its ranking in the global animal health market, key markets, and strategy. It is a general corporate announcement providing high-level information and context, rather than a formal regulatory filing like a 10-K, an earnings release (ER) with specific figures, or a detailed investor presentation (IP). Since it is a general corporate communication that doesn't fit the specific categories like AGM-R, 10-K, ER, or IP, and it is not explicitly announcing the publication of another report (RPA), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous official announcements not covered elsewhere. FY 2022
2023-04-24 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.